Clinical Trial Update: Evia/Entovis HF-T Master Study

View source ↗

Summary

The HF-T Master Study evaluating Biotronik's Evia/Entovis CRT device for heart failure indications has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• Evia/Entovis HF-T Master

Snippet

Sponsor: Biotronik SE & Co. KG | Conditions: Indication for Cardiac Resynchronization Therapy (CRT) | Status: COMPLETED